News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,550 Results
Type
Article (41124)
Company Profile (297)
Press Release (653129)
Section
Business (206102)
Career Advice (2027)
Deals (35681)
Drug Delivery (85)
Drug Development (81192)
Employer Resources (168)
FDA (16224)
Job Trends (15000)
News (348031)
Policy (32914)
Tag
Academia (2614)
Alliances (49910)
Alzheimer's disease (1241)
Approvals (16155)
Artificial intelligence (131)
Bankruptcy (358)
Best Places to Work (11608)
Biotechnology (210)
Breast cancer (120)
Cancer (1094)
Cardiovascular disease (99)
Career advice (1694)
Cell therapy (234)
Clinical research (64451)
Collaboration (390)
Compensation (200)
COVID-19 (2581)
C-suite (96)
Data (1129)
Diabetes (152)
Diagnostics (6311)
Earnings (85285)
Employer resources (146)
Events (110322)
Executive appointments (311)
FDA (16764)
Funding (359)
Gene therapy (179)
GLP-1 (588)
Government (4377)
Healthcare (18810)
Infectious disease (2667)
Inflammatory bowel disease (106)
Interviews (312)
IPO (16374)
Job creations (3749)
Job search strategy (1449)
Layoffs (416)
Legal (7977)
Lung cancer (173)
Manufacturing (177)
Medical device (13244)
Medtech (13249)
Mergers & acquisitions (19385)
Metabolic disorders (404)
Neuroscience (1516)
NextGen Class of 2024 (6541)
Non-profit (4522)
Northern California (1484)
Obesity (233)
Opinion (182)
Patents (102)
People (56928)
Phase I (20031)
Phase II (28371)
Phase III (21159)
Pipeline (460)
Postmarket research (2578)
Preclinical (8614)
Radiopharmaceuticals (237)
Rare diseases (220)
Real estate (6104)
Regulatory (21836)
Research institute (2373)
Resumes & cover letters (351)
Southern California (1308)
Startups (3608)
United States (13583)
Vaccines (555)
Weight loss (169)
Date
Today (41)
Last 7 days (673)
Last 30 days (3644)
Last 365 days (35897)
2024 (32951)
2023 (40335)
2022 (51429)
2021 (56019)
2020 (54507)
2019 (46977)
2018 (35334)
2017 (32519)
2016 (31991)
2015 (38024)
2014 (31875)
2013 (26998)
2012 (29132)
2011 (29788)
2010 (27845)
Location
Africa (731)
Arizona (194)
Asia (37938)
Australia (6203)
California (3344)
Canada (1299)
China (252)
Colorado (149)
Connecticut (153)
Europe (81555)
Florida (461)
Georgia (117)
Illinois (345)
Indiana (197)
Kansas (96)
Maryland (581)
Massachusetts (2616)
Michigan (158)
Minnesota (278)
New Jersey (964)
New York (969)
North Carolina (718)
Northern California (1484)
Ohio (140)
Pennsylvania (849)
South America (1123)
Southern California (1308)
Texas (470)
Utah (92)
Washington State (365)
694,550 Results for "forest laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Biotech Beach
Convergent Research Announces Major New Funding Commitment to Forest Neurotech
Convergent Research today announced a new $14 million funding commitment from former Google CEO Eric Schmidt to Forest Neurotech, an initiative designed to create next-generation brain-computer-interfaces (BCIs) for individuals with neurological injuries or diseases.
March 11, 2024
·
2 min read
Biotech Bay
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data at CMR 2024 demonstrating favorable effects on cardiac structure, function and fibrosis related to treatment with aficamten in FOREST-HCM.
January 25, 2024
·
10 min read
Biotech Bay
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Cytokinetics, Incorporated announced additional 48-week data from FOREST-HCM, the open label extension clinical study of aficamten in patients with hypertrophic cardiomyopathy, at the 73rd Annual American College of Cardiology Scientific Session taking place from April 6, 2024 –April 8, 2024 in Atlanta, GA.
April 5, 2024
·
10 min read
Biotech Bay
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced additional 48-week data from FOREST-HCM the open label extension clinical study of aficamten in patients with hypertrophic cardiomyopathy (HCM), at the 73rd Annual American College of Cardiology (ACC) Scientific Session taking place from April 6, 2024 –April 8, 2024.
April 5, 2024
·
10 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Biotech Bay
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
bioLytical Laboratories Inc., a global leader in rapid diagnostic tests, proudly announces the immediate availability of its INSTI® HCV Antibody Test in the Australian market.
May 19, 2024
·
4 min read
BioMidwest
Kraig Biocraft Laboratories Increases Spider Silk Production with Next Generation of Hybrid Eggs Completed
Kraig Biocraft Laboratories, Inc., announces that it has expanded its production of spider silk with the creation of the next generation of BAM-1 hybrid.
June 25, 2024
·
2 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
1 of 69,455
Next
